These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
514 related articles for article (PubMed ID: 24772574)
1. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method. Thamlikitkul V; Tiengrim S J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574 [TBL] [Abstract][Full Text] [Related]
2. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii. Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805 [TBL] [Abstract][Full Text] [Related]
3. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains]. Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912 [TBL] [Abstract][Full Text] [Related]
5. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii. Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334 [TBL] [Abstract][Full Text] [Related]
6. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii. Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760 [TBL] [Abstract][Full Text] [Related]
7. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates]. Turk Dagi H; Kus H; Arslan U; Tuncer I Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii. Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant Abdel Halim RM; Saber SM; Fahim NAE J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530 [No Abstract] [Full Text] [Related]
12. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii. Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919 [TBL] [Abstract][Full Text] [Related]
13. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii. Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259 [TBL] [Abstract][Full Text] [Related]
14. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
15. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii. Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains]. Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368 [TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii. Marie MA; Krishnappa LG; Alzahrani AJ; Mubaraki MA; Alyousef AA Bosn J Basic Med Sci; 2015 Oct; 15(4):24-9. PubMed ID: 26614848 [TBL] [Abstract][Full Text] [Related]
19. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii. Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235 [TBL] [Abstract][Full Text] [Related]
20. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases. Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]